Selectis Health (GBCS) EPS (Weighted Average and Diluted) (2017 - 2025)
Historic EPS (Weighted Average and Diluted) for Selectis Health (GBCS) over the last 14 years, with Q3 2025 value amounting to $0.24.
- Selectis Health's EPS (Weighted Average and Diluted) rose 14615.38% to $0.24 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.28, marking a year-over-year increase of 8444.44%. This contributed to the annual value of -$0.8 for FY2024, which is 3911.02% up from last year.
- As of Q3 2025, Selectis Health's EPS (Weighted Average and Diluted) stood at $0.24, which was up 14615.38% from -$0.1 recorded in Q2 2025.
- In the past 5 years, Selectis Health's EPS (Weighted Average and Diluted) registered a high of $1.32 during Q1 2023, and its lowest value of -$1.2 during Q4 2023.
- Its 5-year average for EPS (Weighted Average and Diluted) is -$0.19, with a median of -$0.22 in 2025.
- Per our database at Business Quant, Selectis Health's EPS (Weighted Average and Diluted) surged by 450763.73% in 2021 and then crashed by 155000.0% in 2022.
- Selectis Health's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.64 in 2021, then dropped by 12.28% to -$0.72 in 2022, then crashed by 66.61% to -$1.2 in 2023, then skyrocketed by 84.34% to -$0.19 in 2024, then surged by 227.69% to $0.24 in 2025.
- Its EPS (Weighted Average and Diluted) stands at $0.24 for Q3 2025, versus -$0.1 for Q2 2025 and -$0.22 for Q1 2025.